1-20 of 44
Section: Heart failure/cardiomyopathy
Save search
Sort by
Journal Article

Acute effects of empagliflozin on left atrial and ventricular filling parameters using echocardiography—a subanalysis of the EMPAG-HF trial

PDF
Jurgen Bogoviku and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 2, March 2025, Pages 190–197, https://doi.org/10.1093/ehjcvp/pvaf003
Published: 03 March 2025
Journal Article

Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists and sodium–glucose cotransporter-2 inhibitors in atherosclerotic cardiovascular disease phenotypes: a systematic review and meta-analysis

PDF
Yu-Min Lin and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 2, March 2025, Pages 174–189, https://doi.org/10.1093/ehjcvp/pvae093
Published: 10 February 2025
Journal Article

Reduction of hypokalaemia with finerenone: a drug or class-specific effect?

PDF
Giuseppe M C Rosano and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 20–21, https://doi.org/10.1093/ehjcvp/pvae089
Published: 08 January 2025
Journal Article

Cholinesterase inhibitors and reduced risk of hospitalization and mortality in patients with Alzheimer's dementia and heart failure

PDF
Marianne Reimers-Wessberg and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 22–33, https://doi.org/10.1093/ehjcvp/pvae091
Published: 07 January 2025
Journal Article

Pharmacotherapy of patients with heart failure and atrial fibrillation: let's get the evidence!

PDF
Mark Luedde and Samuel Sossalla
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 5–6, https://doi.org/10.1093/ehjcvp/pvae088
Published: 28 December 2024
Journal Article

The untapped potential of guideline-directed heart failure pharmacotherapy: consequences of missed opportunities

PDF
Ester J Herrmann and Samuel Sossalla
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 2, March 2025, Pages 107–108, https://doi.org/10.1093/ehjcvp/pvae096
Published: 24 December 2024
Journal Article

Will mineralocorticoid receptor antagonists give impact on HFpEF pharmacotherapy in addition to SGLT2 inhibitors?

PDF
Maki Komiyama and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 3–4, https://doi.org/10.1093/ehjcvp/pvae082
Published: 29 October 2024
Journal Article

The impact of sodium–glucose cotransporter 2 inhibitors in post-myocardial infarction management: insights from EMPACT-MI and DAPA-MI trials

PDF
Eri Toda Kato and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 6, September 2024, Pages 486–487, https://doi.org/10.1093/ehjcvp/pvae053
Published: 10 July 2024
Journal Article

New ways of mitigating aldosterone in cardiorenal disease

PDF
Felix Götzinger and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 6, September 2024, Pages 557–565, https://doi.org/10.1093/ehjcvp/pvae049
Published: 10 July 2024
Journal Article

Non-coding RNA therapeutics in the treatment of heart failure

PDF
Aleksandra Paterek and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 4, July 2024, Pages 353–360, https://doi.org/10.1093/ehjcvp/pvae027
Published: 19 April 2024
Journal Article

Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries

PDF
Markus Wallner and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 4, July 2024, Pages 296–306, https://doi.org/10.1093/ehjcvp/pvae026
Published: 17 April 2024
Journal Article

Effects of sodium-glucose co-transporter 2 inhibitors on heart failure events in chronic kidney disease: a systematic review and meta-analysis

PDF
Marieta P Theodorakopoulou and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 4, July 2024, Pages 329–341, https://doi.org/10.1093/ehjcvp/pvae003
Published: 13 January 2024
Journal Article

The role of inotropes in cardiogenic shock: to help, to harm or do nothing at all?

PDF
Melissa Fay Lepage-Ratte and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 2, March 2024, Pages 98–99, https://doi.org/10.1093/ehjcvp/pvad098
Published: 11 December 2023
Journal Article

SGLT2 inhibitors in acute myocardial infarction: what can we learn from the DAPA-MI trial? More news from American Heart Association Scientific Meeting

PDF
Eri Toda Kato and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 2, March 2024, Pages 95–97, https://doi.org/10.1093/ehjcvp/pvad099
Published: 07 December 2023
Journal Article

Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials

PDF
Chiara Oriecuia and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 2, March 2024, Pages 147–157, https://doi.org/10.1093/ehjcvp/pvad088
Published: 20 November 2023
Journal Article
EDITOR'S CHOICE

A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies

PDF
Joanna Osmanska and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 1, January 2024, Pages 35–44, https://doi.org/10.1093/ehjcvp/pvad073
Published: 06 October 2023
Journal Article

Initiation of eplerenone or spironolactone, treatment adherence, and associated outcomes in patients with new-onset heart failure with reduced ejection fraction: a nationwide cohort study

PDF
Johan E Larsson and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 6, September 2023, Pages 546–552, https://doi.org/10.1093/ehjcvp/pvad045
Published: 24 June 2023
Journal Article

Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction

PDF
Davide Stolfo and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 6, September 2023, Pages 526–535, https://doi.org/10.1093/ehjcvp/pvad036
Published: 18 May 2023
Journal Article

Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish heart failure registry

PDF
Peter Moritz Becher and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 4, June 2023, Pages 343–352, https://doi.org/10.1093/ehjcvp/pvad012
Published: 30 January 2023
Journal Article

A dose–response relationship of renin–angiotensin system blockers and beta-blockers in patients with acute heart failure syndrome: a nationwide prospective cohort study

PDF
Kyung An Kim and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 6, October 2022, Pages 587–599, https://doi.org/10.1093/ehjcvp/pvac002
Published: 28 January 2022